Small molecule-based Life-span extension therapy: Phosphorylated glucosamine inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 15/April/2015, 22.58

Molecular therapy for pulmonary arterial hypertension: 3-caffeoyl, 4-dihydrocaffeoylquinic acid (CDCQ) inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 15/April/2015, 21.55
April 15, 2015
Molecular therapy for acute respiratory distress syndrome: GATA-binding factor 6 inhibits acute lung injury via down regulation of its target gene, 15/April/2015, 22.04
April 15, 2015
Show all

A recent study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 )by Prof Dominic J. Withers, Dr. Selman C and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports that: Small molecule-based Life-span extension therapy: Phosphorylated glucosamine inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Significance: This study suggests that Phosphorylated glucosamine, by increasing the expression of its target gene, it may decrease the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase). Thereby, it may promote (1) resistance to bone, immune, and motor dysfunction; and (2) insulin sensitivity.  Thus, pharmacological formulations encompassing Phosphorylated glucosamine or its analogues may be used to extend the life span of an individual.

CitationBoominathan, Small molecule-based Life-span extension therapy: Phosphorylated glucosamine inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 15/April/2015, 22.59, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Phosphorylated glucosamine decreases the expression of p70S6 Kinase

Comments are closed.